News & Events

This event will provide junior engineers, early researchers and medical doctors with an integrative view of state-of-the-art research for in silico medicine, following a complete pipeline from basic science and clinical needs, to model application.

The key methodological and technological concepts are enriched by afternoon hands-on sessions that stand for 15,5 hours of transversal training in in silico medicine technologies.

Within this 1st WI3R symposium the German Research Foundation (DFG) will grant the Ursula M. Händel Prize to scientists who have made exemplary and sustained efforts to improve the welfare of animals in research. In particular, this includes the development of methods that contribute to the reduction, refinement and replacement of animal experiments. The €80,000 Ursula M. Händel Animal Welfare Prize is currently the largest prize of its kind in Germany, awarded every two years.

Save the date for the MPS World Summit 2024, organized by the Johns Hopkins Center for Alternatives to Animal Testing (CAAT), with the support of more than forty organizations.

More information will follow soon.

IC-3Rs organizes a webinar series on the 4Rs (Replacement, Refinement, Reduction & Responsibility). The fourth webinar will welcome Prof. Dr. Sophie Hernot who will discuss 'The retrospective analysis as important tool for all stakeholders'.

Registration is free of charge but mandatory.

The 3Rs Centre Utrecht and the Transition to Animal-free Innovations are organising  together with TPI-Utrecht and the National Committee for the protection of animals used for scientific purposes, a conference aiming to connect NAMs to the 3Rs framework, exploring the best way forward for human-based biomedical basic and translational science.

The programme of the conference will soon be posted and will consist of presentations and (interactive) panel discussions in multiple thematic sessions.

LIVe2024 intends to be a unique exchange platform for scientists interested in in vitro respiratory researches, stakeholders from academia, pharma, biotech, chemical, tobacco, consumer goods, medical devices industries, CROs and regulatory agencies.

The meeting focuses on predictive in vitro lung models designed for basic research, efficacy and toxicity testing. It aims to present the state-of-art of in vitro lung models, and to map out the route for its future development and use.

The course aims at providing state-of-the-art knowledge on the recent developments in toxicological hazard and risk assessment. A limited number of lectures will provide insights in these developments, emphasizing the role of so-called New Approach Methodologies (NAMs). It includes 2 online webinars on 28 May 2024 and 30 May 2024, 2 days of in-person training on 2 & 3 July 2024 and a follow up online call on 29 August 2024

Register before 30 April 2024!

The EUROoCS2024 Conference will showcase the latest scientific advancements in the field and favour discussions on technological, industrial and regulatory challenges/opportunities. Topics such as (multi)-organ and disease models, organoids-on-chip, PK/PD modelling, technology platforms, read-out assays, standardization and qualification and toxicity among others, will be addressed.

Deadline for abstract submission: 15/01/2024.